- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
On this final Oncology Onward episode of 2023, cohosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, talk with Penn Medicine’s Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation. Their conversation encapsulates much of what has been discussed in the oncology space in the past year, from the unique perspective of academic medicine: the importance of collaboration between academic medical centers and community oncology practices and testing innovative cancer care delivery in academic and community settings to have the greatest impact on patients.
“If we can only show that a certain innovation works at Penn Medicine or an academic practice, it's very limited—it's useful, but it's very limited,” Bekelman says. “If we want to demonstrate as part of our mandate to generalize knowledge across the country, we have to be able to extend programs into the community, learn from the community, test things that are working in the community in academic environments, create a bidirectional approach that allows for expertise from both systems to create the best possible opportunities for patients with cancer.”
For interview audio:
Listen above or on one of these podcast services:
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
